Efficacy of neoadjuvant immunotherapy in advanced colorectal cancer: a meta-analysis of cross-sectional studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-022-04402-6.pdf
Reference19 articles.
1. Avallone A, De Stefano A, Pace U et al (2020) 491P neoadjuvant nivolumab in early stage colorectal cancer. Ann Oncol 31:S449. https://doi.org/10.1016/j.annonc.2020.08.602
2. Carrasco J, Schröder D, Sinapi I et al (2021) 397P R-IMMUNE interim analysis: a phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer. Ann Oncol 32:S537. https://doi.org/10.1016/j.annonc.2021.08.919
3. Chalabi M, Fanchi L, Dijkstra K et al (2020) Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med 26(4):566–576. https://doi.org/10.1038/s41591-020-0805-8
4. Deng Y, Chi P, Lan P et al (2020) Neoadjuvant modified folfox6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol : off J Am Soc Clin Oncol 37(34):3223–3233. https://doi.org/10.1200/jco.18.02309
5. Diaz LA, Shiu K-K, Kim T-W et al (2022) Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol 23(5):659–670. https://doi.org/10.1016/s1470-2045(22)00197-8
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3